SPL 0.00% 11.5¢ starpharma holdings limited

@bid compliance may have been one issue affecting the results...

  1. 2,040 Posts.
    lightbulb Created with Sketch. 300
    @bid compliance may have been one issue affecting the results but one observation that stuck in my mind was that the test results were based on tests on day 7 only.

    I read a theory, l think somewhere in HC, that the younger participants more than likely had recovered by day 7 as younger people generally do from the common cold or flu therefore the results on that basis alone showed no statistical significance.

    This means the trial may have shown different more favourable results if testing was conducted on day 5 or 6 for example.

    Given this theory, which to me sounds very feasible, then you could say the trial design was flawed perhaps causing a lost golden opportunity.

    Any comments welcome.
    Last edited by chrisnj: 26/02/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.000(0.00%)
Mkt cap ! $47.38M
Open High Low Value Volume
11.5¢ 12.0¢ 11.5¢ $6.791K 58.99K

Buyers (Bids)

No. Vol. Price($)
4 132768 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 203978 10
View Market Depth
Last trade - 11.21am 21/05/2024 (20 minute delay) ?
Last
11.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
11.5¢ 11.5¢ 11.5¢ 10000
Last updated 11.21am 21/05/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.